Induction of labor with mifepristone (RU 486) in intrauterine fetal death. 1990

D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
Clinique Universitaire Baudelocque, Paris, France.

In a double-blind controlled multicentric study involving 94 patients with an intrauterine fetal death, we investigated the efficacy and tolerance of mifepristone (RU 486), a steroid compound that antagonizes progesterone action at the receptor level. Success of treatment was defined as the occurrence of fetal expulsion within 72 hours after the first drug intake. Mifepristone treatment (600 mg per day for 2 days) was considered to be effective in 29 of 46 patients (63%). There were only eight successes in 48 patients (17.4%) in the placebo group (p = 0.001, chi 2 test). Tolerance was good in the mifepristone group. In the placebo group, disseminated intravascular coagulation occurred in one woman for whom the investigator waited several weeks for spontaneous expulsion. This large double-blind controlled study provides evidence that mifepristone is of interest in the management of intrauterine fetal death. It could provide a pharmacologic alternative to the use of prostaglandins in this indication.

UI MeSH Term Description Entries
D007751 Labor, Induced Artificially induced UTERINE CONTRACTION. Induced Labor,Induction of Labor,Labor Induced,Labor Induction,Induced, Labor,Induction, Labor,Inductions, Labor,Labor Inductions
D010120 Oxytocics Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D005313 Fetal Death Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH. Fetal Mummification,Fetal Demise,Death, Fetal,Deaths, Fetal,Demise, Fetal,Fetal Deaths,Mummification, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
November 1985, Lancet (London, England),
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
January 1992, Diskussionsforum medizinische Ethik,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
June 1992, The Western journal of medicine,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
March 1990, The New England journal of medicine,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
December 1990, The Medical letter on drugs and therapeutics,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
January 1993, Archives of family medicine,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
October 2000, The Medical letter on drugs and therapeutics,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
January 1990, Zentralblatt fur Gynakologie,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
July 1979, Nederlands tijdschrift voor geneeskunde,
D Cabrol, and C Dubois, and H Cronje, and J M Gonnet, and M Guillot, and B Maria, and J Moodley, and J F Oury, and J M Thoulon, and A Treisser
January 2007, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!